European Archives - Page 64 of 899 - European Medical Journal

Effective Meningioma Images Despite Reduced Gadolinium

Research shows reducing gadolinium dose by 62% in MRI imaging maintains clarity in distinguishing meningiomas from healthy brain tissue.

a person standing on scales and a tape measure

Endocrinology: The Hidden Drivers of Hunger and Weight – Part 1

Exploring the relationship between food intake and metabolic health, this episode investigates how to advise patients on weight management.

Disparities in Kidney Transplant Access for Black Adults

Black adults may have significantly lower access to both deceased donor and live donor kidney transplants compared to White adults

Cardiac Outcomes and Kidney Complications in Adults with Obesity

A recent study has found that adults with class II to III obesity face an increased risk of poor cardiac outcomes, though they do not have a higher risk for kidney complications.

Increased Mortality Amongst Weekend Admissions

Weekend admission has been linked to higher mortality risk and post-procedure morbidity amongst patients entering hospital for transjugular intrahepatic portosystemic shunt.

Phone in someone's hand with medical imagery on it

From basic to bold: Introducing interactive medical education

A 3D, interactive approach allows pharmaceutical companies to share the latest medical breakthroughs in a more dynamic and engaging way.

Fish Intake Linked to Juvenile Arthritis Risk: EULAR 2024 Findings

New data has linked the consumption of fish during pregnancy and the first year of life with juvenile idiopathic arthritis.

Novel Treatments for Systemic Sclerosis: EULAR 2024 Findings

EULAR has updated its recommendations for systemic sclerosis, incorporating four new therapies presented at its congress in 2024.

Biomedical Alliance in Europe: A Roundtable Discussion

Tune in to the latest EMJ Webinar, featuring three of the Biomedical Alliance in Europe’s most valued members, who join host Jonathan…

New MS blood test to launch in Europe

Siemens Healthineers has received CE Mark approval for its test for the management of relapsing multiple sclerosis, allowing it to be launched in Europe.